Search

everythinglearnresearchcommunity

for

Search:↓

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

Higher minoxidil dose helps hair growth in non-responders without side effects.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

Chemotherapy and radiation therapy cause skin and hair damage by altering gene expression and signaling pathways.

Early and late matrix progenitors in hair follicles create different cell layers, with early ones forming the companion layer and later ones forming the inner root sheath and hair shaft.

Sweat glands and hair follicles are determined by opposing signals, with BMPs promoting sweat glands and blocking BMPs leading to hair follicles.

Researchers improved a method to study individual cells in newborn mouse skin and found a way to assess the severity of a skin condition in humans.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Fat tissue-derived cells show promise for repairing body tissues, but more research and regulation are needed for safe use.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Cytokeratin 19 and cytokeratin 15 are key markers for monitoring the quality and self-renewing potential of engineered skin.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Older skin has higher cancer risk due to inflammation and stem cell issues.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Different markers are found in stem cells of the scalp's hair follicle bulge and the surrounding skin.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Iron deficiency might contribute to hair loss in women.

Blood-derived CD34+ cells speed up healing, reduce scarring, and regrow hair in skin wounds.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

A group has developed therapies that show promise for treating cancer and various other conditions.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

The document provides 70 multiple choice questions to improve haematology skills.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.